This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
FOx Biosystems
Visit WebsiteFOx BIOSYSTEMS’s mission is to revolutionize the Life Science and Pharmacological research markets with innovative real-time, label-free analysis products.
The basis of the company’s success is a novel fibre-optic-based surface plasmon resonance (FO-SPR) biosensor which enables users to generate high-quality, cost-effective biomolecular data accurately, fast, and over a wide range of applications. The White Fox technology uses an innovative fibre-optic probe setup which combines a fluidics-free dip-in protocol with the precision and speed of surface plasmon resonance (SPR). This means it can be used directly in complex samples, like lysates, whole blood or large particles. The probes can be switched easily to allow the detection of different target molecules, including antibodies, nanobodies, microvesicles, phage and small molecules, with a single device.
Subsidiaries
Portfolio
- ProAxsis
- Glycotest
- Cetromed
- PDS Biotechnology
- Vortex Biosciences
- Wanda Health
- Q-Bot
- Sofant Technologies
- PointGrab
- SageTech Medical
- Dname-iT
- Oncocidia
- Ventive
- DeepTech Recycling
- G-Tech Medical
- FOx Biosystems
- EpiBone
- Cytovale
- Longevity Biotech
- QuantalX Neuroscience
- Insight Photonics
- Nanotech Industrial Solutions
- Martlet Capital